Mozez Singh to re-unite Shabana Azmi and Shefali Shah for his next medical thriller

Published: Jun 25, 2019, 13:43 IST | Letty Mariam Abraham

Filmmaker Mozez Singh to make his television debut with a medical thriller which stars Shabana Azmi and Shefali Shah.

Mozez Singh to re-unite Shabana Azmi and Shefali Shah for his next medical thriller
Shabana Azmi and Shefali Azmi

Bollywood's ace director and producer, Mozez Singh, is all set to step into the world of Television with his upcoming project, a medical thriller show starring two uber pool of talents, Shabana Azmi and Shefali Shah.

The leading ladies will be reuniting in Mozez's TV show after featuring in the National award-winning film 15 Park Avenue after almost 14 years. While speaking to sources Mozez added that it will be his ultimate dream to direct two of India's most superb actors, Shabana and Shefali, and we couldn't agree more.

The thriller was initially touted to be a film but due to the short time frame of movies, Mozez Singh was brought in to transform the project to make it into a TV show and he dived right into it from the day he joined. He built up the story in a way that would keep the original concept intact and yet be entertaining and apt for a TV show.

This series is inspired by real-life events and occurrences that take place in hospitals with Shefali Shah portraying the role of a doctor and Shabana Azmi essaying the role of her boss and the owner of the hospital. Conflicts, relationships and the lives of these characters is the exciting gist of the show and we can't wait to see Mozez work his charm and make it amazing.

Catch up on all the latest entertainment news and gossip here. Also download the new mid-day Android and iOS apps to get latest updates

Sign up for all the latest news, top galleries and trending videos from Mid-day.com

Subscribe
Loading...

Exclusive! Diljit Dosanjh reveals why he talks less

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK